Susquehanna International Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-23,600
Closed -$3.22M 12070
2020
Q3
$3.22M Sell
23,600
-101,600
-81% -$10.8M ﹤0.01% 3737
2020
Q2
$12.1M Sell
125,200
-374,300
-75% -$31.2M ﹤0.01% 1919
2020
Q1
$23.4M Buy
499,500
+445,400
+823% +$28.5M 0.01% 1080
2019
Q4
$3.94M Buy
54,100
+4,700
+10% +$285K ﹤0.01% 3312
2019
Q3
$2.58M Buy
49,400
+25,500
+107% +$1.36M ﹤0.01% 3746
2019
Q2
$1.2M Sell
23,900
-26,200
-52% -$1.28M ﹤0.01% 5247
2019
Q1
$2.6M Sell
50,100
-19,900
-28% -$917K ﹤0.01% 3367
2018
Q4
$3.42M Sell
70,000
-20,700
-23% -$1.14M ﹤0.01% 2747
2018
Q3
$5.91M Buy
90,700
+36,700
+68% +$2.16M ﹤0.01% 2481
2018
Q2
$2.68M Buy
54,000
+33,100
+158% +$1.6M ﹤0.01% 3558
2018
Q1
$1.02M Buy
+20,900
New +$1.09M ﹤0.01% 5203

Susquehanna International Group's MYOK Position: Q4 2020 in Review

Susquehanna International Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 20,088 shares — an estimated $2.74M sold.

Susquehanna International Group first reported a position in MYOK in Q4 2015 and held it in 10 quarters. The position peaked at $8.61M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Susquehanna International Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Susquehanna International Group sold 20,088 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.74M.
  • Susquehanna International Group first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
  • Susquehanna International Group's MyoKardia, Inc. Common Stock position peaked at $8.61M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.